Lodoxamide

This classification denotes a mast cell stabilizer with the molecular formula C11H6ClN3O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SPU695OD73, chemically known as n,n-(2-chlor-5-cyan-3-phenylen)dioxamsaeure but generally known as lodoxamide, which bears US NIH Compound Identifier 44564. European Medicines Agency schedules Lodoxamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08553MIG. The term LODOXAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules lodoxamide in its Anatomical Therapeutic Chemical (ATC) Classification. LODOXAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lodoxamide under HS 29269095 and SITC 51484. As of Q4 2014, LODOXAMIDE remains the US FDA Preferred Term for this commodity. Lodoxamide bears US NLM identifiers UMLS ID C0126120 and NCI Concept Code C61813. SMILES: C1=C(C=C(C(=C1NC(=O)C(=O)O)CL)NC(=O)C(=O)O)C#N.